Abeona Therapeutics (ABEO) Debt to Equity (2016 - 2025)
Historic Debt to Equity for Abeona Therapeutics (ABEO) over the last 11 years, with Q3 2025 value amounting to $0.12.
- Abeona Therapeutics' Debt to Equity fell 7169.05% to $0.12 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.12, marking a year-over-year decrease of 7169.05%. This contributed to the annual value of $0.43 for FY2024, which is N/A changed from last year.
- As of Q3 2025, Abeona Therapeutics' Debt to Equity stood at $0.12, which was down 7169.05% from $0.12 recorded in Q2 2025.
- Abeona Therapeutics' 5-year Debt to Equity high stood at $0.72 for Q3 2022, and its period low was -$2.04 during Q1 2024.
- Its 4-year average for Debt to Equity is $0.2, with a median of $0.36 in 2021.
- Within the past 5 years, the most significant YoY rise in Abeona Therapeutics' Debt to Equity was 12288.61% (2025), while the steepest drop was 7169.05% (2025).
- Quarter analysis of 4 years shows Abeona Therapeutics' Debt to Equity stood at $0.2 in 2021, then dropped by 21.79% to $0.16 in 2022, then soared by 176.85% to $0.43 in 2024, then tumbled by 73.22% to $0.12 in 2025.
- Its Debt to Equity was $0.12 in Q3 2025, compared to $0.12 in Q2 2025 and $0.47 in Q1 2025.